Technical analysis of Reviva Pharmaceuticals Holdings, Inc. (RVPH): price and volume charts, candlestick patterns, moving averages (SMA, EMA), RSI, MACD, ADX and Bollinger Bands. Identify momentum, trend direction and potential entry/exit zones.
Reviva Pharmaceuticals Holdings, Inc., a biopharmaceutical company, discovers, develops, and commercializes next-generation therapeutics for diseases targeting unmet medical needs in the areas of central nervous system, respiratory, inflammatory, and cardiometabolic diseases.
Price Performance
| 1 month | +6.52% |
| 3 months | -19.67% |
| Year-to-date | -91.22% |
| 1 year | -93.94% |
| 3 years | -99.55% |
| 5 years | -99.45% |
52-Week Range
| 52-week High | $17.20 |
| 52-week Low | $0.26 |
| Avg Volume (90d) | 244K |
Technical Indicators
| SMA 50 | $0.50 |
| SMA 200 | $2.97 |
| 30-day Volatility (annualised) | 90.9% |
| Price vs SMA 50 | -1.2% |
| Price vs SMA 200 | -83.5% |
Monthly Close (12 months)
| Month | Close | Change |
|---|
| 2025-10 | $11.99 | |
| 2025-11 | $11.25 | -6.2% |
| 2025-12 | $5.58 | -50.4% |
| 2026-01 | $5.85 | +4.8% |
| 2026-02 | $4.29 | -26.7% |
| 2026-03 | $0.73 | -83.0% |
| 2026-04 | $0.87 | +19.3% |
| 2026-05 | $0.41 | -53.0% |
| 2026-06 | $0.63 | +53.7% |
| 2026-07 | $0.44 | -30.4% |
| 2026-08 | $0.48 | +9.6% |
| 2026-09 | $0.49 | +2.1% |
Upcoming Earnings
| Date | EPS Est. | Revenue Est. |
|---|
| 2026-09-14 | $-2.53 | |
| 2026-09-14 | | $159M |
| 2026-09-14 | $-0.26 | $14M |
| 2026-09-14 | | |
| 2026-09-14 | $0.84 | $26M |
| 2026-09-14 | | |
Price
| Price | $0.49 |
| Market Cap | $6M |
| Exchange | OTC |
| Country | US |
Valuation Ratios
| Price / Book | 0.00 |
| EV / EBITDA | 7.54 |
| Dividend Yield | 0.00% |
Financial Health
| Debt / Equity | 0.01 |
| Current Ratio | 3.56 |
| Piotroski F-Score | 2 |
| Altman Z-Score | -18.12 |